glp 1 drugs thyroid cancer Glucagon-like peptide receptor agonist use and risk of cancer: Scandinavian cohort study Frontiers | Drug repositioning in

Energy metabolism in ALS: An underappreciated opportunity

First described in the 1990s by researchers at the University of Zagreb, it has been studied across a broad range of preclinical models for regenerative and cytoprotective properties

When combined with vitamin B12, these ingredients form a synergistic blend that enhances energy production and supports a more efficient metabolic system

Ferritinophagy induces ferroptosis by regulating intracellular iron homeostasis and ROS generation

The multispecific thyroid hormone transporter OATP1C1 mediates cell-specific sulforhodamine 101-labeling of hippocampal astrocytes